<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02008825</url>
  </required_header>
  <id_info>
    <org_study_id>SLHN2013-62</org_study_id>
    <nct_id>NCT02008825</nct_id>
  </id_info>
  <brief_title>Evaluation of the ViSiGiTM Calibration System</brief_title>
  <acronym>ViSiGi</acronym>
  <official_title>Evaluation of the ViSiGiTM Calibration System for Effectiveness With Sleeve Visual Delineation at Various Suction Levels.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Luke's Hospital and Health Network, Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Luke's Hospital and Health Network, Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesize that using the ViSiGi™ Calibration Tube System in patients undergoing LSG
      will:

        1. enhance delineation of the stomach anatomy and the surgeon's appreciation of the extent
           of gastric volume to be removed;

        2. increase the safety profile of the patient (i.e., reduce the likelihood of accidental
           stapling of the orogastric tube or bougie);

        3. reduce the incidence of OR contamination/infection transmission;

        4. streamline OR workflow, resulting in reduced OR time; and

        5. ensure consistent and reproducible staple lines.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopic Sleeve Gastrectomy (LSG), is now widely used as a stand-alone procedure for
      long-term weight loss. With fewer potential morbidities, comparable weight loss and greater
      ease of conversion to other procedures, many patients now opt for LSG as their bariatric
      procedure of choice. During surgery gastric decompression and calibration are compulsory for
      patient safety, gastric anatomic delineation, ease of surgery and optimal weight loss. The
      removed gastric volume at surgery seems to predict the procedure's success rates2. LSG
      performed without calibration (tube) could result in inconsistent staple lines, with retained
      high sleeve volume and consequent failure. Traditionally, although different tubes are used
      for gastric decompression and calibration, this protocol interrupts operation room (0R)
      workflow. Accidental stapling of orogastric tubes and bougies do occur in the OR but are
      seldom reported. The need for this multiple tube system can be obviated with the ViSiGi™
      Calibration Tube System. A single, multipurpose tube that integrates all these various steps
      could prevent breaks in OR; improve workflow; reduce patient injuries, cross contamination
      and transmission of infections; and a consistent and reproducible staple line. A similar
      device has been in use in Europe, Australia and Asia, but the ViSiGi™ Calibration Tube System
      is the first of its kind to be approved by the FDA. Currently, there are no data on its
      clinical safety/efficacy in comparison to standard care of separate orogastric tube and
      bougie in the United States. Therefore, this exploratory study will investigate the gastric
      delineation ability, general safety and efficacy of the ViSiGi™ Calibration Tube System along
      with the regular bougie in LSG patients over a six- to twelve-month period. Descriptive
      outcomes will be reported, with no formal sample size calculation in light of the exploratory
      study design.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficasy</measure>
    <time_frame>3 months</time_frame>
    <description>This exploratory study will investigate the gastric delineation ability, general safety and efficacy of the ViSiGi™ Calibration Tube System along with the regular bougie in LSG patients over a six- to twelve-month period. Descriptive outcomes will be reported, with no formal sample size calculation in light of the exploratory study design.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Enhance Delineation of the Stomach Anatomy and the Surgeon's Appreciation of the Extent of Gastric Volume to be Removed;</condition>
  <condition>Increase the Safety Profile of the Patient (i.e., Reduce the Likelihood of Accidental Stapling of the Orogastric Tube or Bougie);</condition>
  <condition>Reduce the Incidence of OR Contamination/Infection Transmission;</condition>
  <condition>Streamline OR Workflow, Resulting in Reduced OR Time</condition>
  <condition>Ensure Consistent and Reproducible Staple Lines.</condition>
  <arm_group>
    <arm_group_label>ViSiGi</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Utilization of ViSiGi calibration tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual standard of care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual non suction Bougie</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Utilization of ViSiGi calibration tube</intervention_name>
    <description>Utilization of ViSiGi calibration tube</description>
    <arm_group_label>ViSiGi</arm_group_label>
    <other_name>ViSiGi 3D</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Usual non suction Bougie</intervention_name>
    <description>Usual non suction Bougie</description>
    <arm_group_label>Usual standard of care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ability to provide written informed consent for study participation.

          -  age 18 years or older

          -  candidate for laparosopic gastrectomy with no history of previous bariatric surgeries
             (i.e., gastric bypass, band, duodenal switch)attendance at an informational seminar
             and support group

          -  clearance for surgery by a registered dietician and certified social worker

          -  BMI &gt; 35 with at least one co-morbid condition (e.g., hypertension, diabetes mellitus,
             sleep apnea, hypercholesterolemia) or BMI &gt; 40 without any co-morbid conditions

          -  negative pregnancy test

          -  American Society of Anesthesiology score 1-3

          -  ability to understand instructions and comply with all study requirements

          -  pre-operative %excess weight loss (%EWL) of 3-10%

          -  no contraindication for LSG based on upper endoscopy findings

          -  pre-operative cardiac consultation for risk stratification

          -  evaluation by a sleep medicine specialist to identify risk factors for sleep apnea,
             with treatment as deemed appropriate

        Exclusion Criteria:

          -  current participation in another clinical trial that involves any investigational drug
             or device that would interfere with this study

          -  Barrett's Esophagus, severe gastric paresis/atony, achalasia, neoplasm or other
             complications discovered during preoperative esophago-gastro-duodonoscopy.

          -  revisional surgery

          -  conversion to open procedure

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Leonardo Claros, MD</last_name>
    <phone>4844262600</phone>
    <email>Leonardo.Claros@sluhn.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Saint Luke's University and Health Network</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leonardo Claros</last_name>
      <phone>484-426-2600</phone>
      <email>Leonardo.Claros@sluhn.org</email>
    </contact>
    <investigator>
      <last_name>Leonardo Claros, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maher ElChaar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.visigi.com</url>
    <description>ViSiGi web site</description>
  </link>
  <reference>
    <citation>Satiani B, Bonner JT, Stone HH. Factors influencing intraoperative gastric regurgitation: a prospective random study of nasogastric tube drainage. Arch Surg. 1978 Jun;113(6):721-3.</citation>
    <PMID>26318</PMID>
  </reference>
  <reference>
    <citation>Weiner RA, Weiner S, Pomhoff I, Jacobi C, Makarewicz W, Weigand G. Laparoscopic sleeve gastrectomy--influence of sleeve size and resected gastric volume. Obes Surg. 2007 Oct;17(10):1297-305.</citation>
    <PMID>18098398</PMID>
  </reference>
  <reference>
    <citation>Abu-Gazala S, Donchin Y, Keidar A. Nasogastric tube, temperature probe, and bougie stapling during bariatric surgery: a multicenter survey. Surg Obes Relat Dis. 2012 Sep-Oct;8(5):595-600; discussion 600-1. doi: 10.1016/j.soard.2011.08.017. Epub 2011 Aug 31.</citation>
    <PMID>21963196</PMID>
  </reference>
  <reference>
    <citation>Péquignot A, Dhahria A, Mensah E, Verhaeghe P, Badaoui R, Sabbagh C, Regimbeau JM. Stapling and Section of the Nasogastric Tube during Sleeve Gastrectomy: How to Prevent and Recover? Case Rep Gastroenterol. 2011;5(2):350-4. doi: 10.1159/000329706. Epub 2011 Jul 6.</citation>
    <PMID>21769286</PMID>
  </reference>
  <reference>
    <citation>Sanchez BS, Safadi BY, Kieran JA, Hsu GP, Brodsky JB, Curet MJ, Morton JM. Orogastric tube complications in laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006 Apr;16(4):443-7.</citation>
    <PMID>16608608</PMID>
  </reference>
  <reference>
    <citation>Vennes JA. Infectious complications of gastrointestinal endoscopy. Dig Dis Sci. 1981 Jul;26(7 Suppl):60S-64S. Review.</citation>
    <PMID>6765053</PMID>
  </reference>
  <reference>
    <citation>Kovaleva J, Peters FT, van der Mei HC, Degener JE. Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev. 2013 Apr;26(2):231-54. doi: 10.1128/CMR.00085-12. Review.</citation>
    <PMID>23554415</PMID>
  </reference>
  <reference>
    <citation>Schembre DB. Infectious complications associated with gastrointestinal endoscopy. Gastrointest Endosc Clin N Am. 2000 Apr;10(2):215-32. Review.</citation>
    <PMID>10683209</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2013</study_first_submitted>
  <study_first_submitted_qc>December 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2013</study_first_posted>
  <last_update_submitted>December 10, 2013</last_update_submitted>
  <last_update_submitted_qc>December 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Luke's Hospital and Health Network, Pennsylvania</investigator_affiliation>
    <investigator_full_name>Leonardo Claros</investigator_full_name>
    <investigator_title>Bariatric Section Chief and Program Director</investigator_title>
  </responsible_party>
  <keyword>ViSiGi</keyword>
  <keyword>Calibration tube</keyword>
  <keyword>Sleeve gastrectomy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

